Everolimus - retrospective analysis of therapy with mTor-inhibitors of 38 patients after pediatric HTX

Introduction: Beside the avoidance of a rejection the minimization of side effects of the immunosuppressive therapy is one of the most important aims in the follow up after pediatric heart transplantation. Due to their low nephrotoxic and their antiproliferative effect mTor-inhibitors are getting more and more a component of the standard immunosuppressive therapy after pediatric heart transplantation.